Dr. Buff Mair is the new CTS Medical Director and replaces Dr. German Leparc who retired at the beginning of 2018. Several of the CTS client forms specify list the Medical Director in the header and these forms will be updated on March 5, 2018. Check out the Communication page for a complete list of forms or by clicking the link below: Communications
On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...
This is the first update to the original CTS communication distributed on July 6th. As previously co...
We sincerely hope to see you at this year’s AABB Annual Meeting in San Antonio, TX on October ...
At CTS, we understand the impact converting to the Ortho viral marker platform has on your operation...
CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex...
We received an updated WNV package insert; please note the manufacturer and license number has been ...